Inspection Readiness: Why It Matters & How to Prepare
Webinars

Inspection Readiness: What It Is, Why It Matters, and What You Need to Know to Be Prepared

Organizations must have inspection readiness since inspections can be unannounced or come at any time. Good Clinical Practice (GCP) inspectors use different approaches depending on the regulatory authorities for which they represent; however, all of them will verify the compliance status on GCP and other applicable regulations during the inspection.

Planning ahead to anticipate all processes are compliant means an organization is prepared for an inspection and able to create a solid corrective action and preventative action (CAPA) to minimize risk.

Watch this webinar where Ernesto Vera-Sanchez, MD, PhD, Vice President of GxP Consulting services at Allucent, discusses the ins and outs of preparing for regulatory authority inspections during a drug’s life cycle.

Webinar Agenda

  • Understanding inspection readiness from a regulatory agency standpoint for Good Clinical Practice (GCP)
  • Knowing how an inspection is conducted including important processes for which to be prepared
  • Overcoming challenges in preparing for an inspection with regulatory obligations
  • Preparing an effective corrective action and preventative action (CAPA) to solve deficiencies detected during inspections and avoid them in the future

Speaker

Dr. Ernesto Vera-Sanchez, MD, PhD. Vice President, GxP Strategy Consulting Services

Ernesto Vera-Sanchez has nearly 20 years of experience as a regulator and an EMA and AEMPS GxP Inspector. His comprehensive knowledge of clinical trial regulations and guidance from EMA, FDA, MHRA, and PMDA, as well as his extensive experience in inspection strategy and related procedures, lend to his wide-ranging expertise. Dr. Vera-Sanchez has led over 400 regulatory inspections at clinical investigator sites, CROs, sponsors, and vendors.

Request a Proposal

Partner With the A-Team

Let us know how we can help you bring new therapies to light. Get in touch to get started.

Join the A-Team

Want to help small and mid-size biopharma companies change the therapeutic landscape?

Subscribe to our monthly newsletter